Wize Mirror Spots Signs of Disease in 60 Seconds
(July 27, 2015) – Sweden
Wize Mirror is a self-monitoring system in the form of a mirror which incorporates 3D scanners, multispectral cameras and gas sensors to assess a person’s health. The European Commission funded it as a research project in order to help curb cardio-metabolic disease. Clinical trials are anticipated to begin next year.
A person looking into the mirror will have their face examined for fatty tissue, facial expressions, and skin color (flushness/pale), weight gain/loss, heart rate, and hemoglobin levels. It will utilize gas sensors to detect signals of smoking or drinking. The health analysis takes 60 seconds, after which it will offer advice like “stop drinking” or “exercise more.”[caption id="" align="alignleft" width="315"] Wikimedia/Creative Commons[/caption]
The current cost of the health care system is burdened by expensive and often ineffective diagnostics along with an aging population, according to the mirror makers, and is particularly true in the case of cardiovascular and metabolic disease. The Wize Mirror focuses on diagnosis, education, and prevention as the most effective strategy to reduce the cost and pervasiveness of associated diseases.
“Prevention is the most viable approach to reduce the socio-economic burden of chronic and widespread diseases, such as cardiovascular and metabolic diseases,” according to the European consortium.
This includes ten partners from 7 countries (France, Greece, Italy, Norway, Spain, Sweden, United Kingdom). Six research institutions, both ICT and medical, and four industries are involved in the project coordinated by the Italian National Council of Researches (CNR). Three medical centers located in Pisa, Milan, and Lyon will support research and industrial partners and will host the Wize Mirror testing.
From Linköping University press release:
Moving medical semeiotics to the digital realm
According to medical semeiotics, human face is a precious revealer of key information about the healthy or unhealthy status of individuals. The central idea in SEMEOTICONS, which stands for SEMEiotic Oriented Technology for Individual’s CardiOmetabolic risk self-assessmeNt and Selfmonitoring, is to exploit the face as a major indicator of individual’s well-being by tracing traits of physical and expressive status. In accordance to a semeiotics viewpoint, face signs will be mapped to measures and computational descriptors, automatically assessed. SEMEOTICONS will design and construct an innovative multisensory system integrated into a hardware platform having the exterior aspect of a mirror: the socalled “Wize Mirror”. This will easily fit into users’ home or other sites of their daily life (e.g. fitness and nutritional centers, pharmacies, schools and so on).
Daily self-monitoring of individuals’ wellness[caption id="" align="alignright" width="329"] Wikimedia[/caption]
The Wize Mirror will collect data mainly in the form of videos and images. These will be processed by advanced dedicated methods to extract biometric, morphometric, colorimetric, and compositional descriptors derived from individual’s face. The “wellness index”, derived from the integration of such descriptors into a Virtual Individual’s Model, will trace and monitor the daily evolution of individual’s status. Suggestions and coaching messages will be provided to foster the maintenance of a correct lifestyle or reduce noxious habits. Users will be enabled to share data in their diary with health professionals so as to receive, when needed, direct expert guidance and support.
Wize Mirror validation
Medical experts will validate the system with respect to the reproducibility of measurements, the efficacy in detecting changes in well-being and cardio-metabolic status as well as the acceptability by the end-users.
The exploitation of the Wize Mirror is expected promote new aggregations between health and well-being actors including industry, fitness, and schools. Furthermore, significant effects towards the development of new prevention strategies of cardio-metabolic diseases are expected, with positive impacts on the reduction of avoidable disease burden and health expenditures.